Calcium- and Calmodulin-Dependent PMA-Activation of the CD44 Adhesion Molecule

References

• Bartolazzi A., Peach R., Aruffo A., Stamenkovic I. Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J. Exp. Med 1994; 180: 53–66
   PubMed Web of Science ®Google Scholar
• Bartolazzi A., Noks A., Aruffo A., Spring F., Stamenkovic I. Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J. Cell Biol 1996; 132: 1199–1208
   PubMed Web of Science ®Google Scholar
• Bennett K. L., Modrell B., Greenfield B., Bartolazzi A., Stamenkovic I., Peach R., Jackson D. G., Spring F., Aruffo A. Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J. Cell Biol 1995; 131: 1623–1633
   PubMed Web of Science ®Google Scholar
• Blumberg P. M. Protein kinase C as the receptor for the phorbol ester tumor promoters: sixth Rhoads memorial award lecture. Cancer Res 1988; 48: 1–8
   PubMed Web of Science ®Google Scholar
• Bostwick J. R., Abbe R., Appel S. H. Modulation of acetylcholine release in rat hippocampus by aminoalcohols and Bay K8644. Brain Res 1993; 629: 79–87
   PubMed Web of Science ®Google Scholar
• Bourguignon L. Y., Lokeshwar V. B., Chen X., Kerrick W. G. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction. J. Immunol 1993; 151: 6634–6644
   PubMed Web of Science ®Google Scholar
• Brown T. A., Bouchard T., Wayner St. J.E., Carter W. G. Human keratinocytes express a new CD44 core protein (CD44E) as a heparan sulfate intrinsic membrane proteoglycan with additional exons. J. Cell Biol 1991; 113: 207–221
   PubMed Web of Science ®Google Scholar
• Cao Y.-Z., Reddy C., Mastro A. M. Evidence for protein kinase C independent activation of phospholipase D by phorbol esters in lymphocytes. Biochem Biophys. Res. Comm 1990; 177: 955–962
   Web of Science ®Google Scholar
• Cato A. C., Wade E. Molecular mechanisms of anti-inflammatory action of glucocorticoids. Bioassays 1996; 18: 371–378
   PubMed Web of Science ®Google Scholar
• Coll M. J., Serratosa J., Bachs O., Gahmberg C. G., Enrich C. Calmodulin may decrease cell surface sialic acid and be involved in the expression of fibronectin during liver regeneration. FEBS Letter 1986; 208: 418–422
   PubMed Web of Science ®Google Scholar
• Conquer J. A., Kandel R. A., Cruz T. F. Interleukin-1 and phorbol 12-myristate 13-acetate induce collagenase and PGE2 production through a PKC-independent mechanisms in chondrocytes. Biochem. Biophys. Acta 1992; 1134: 1–6
   PubMed Web of Science ®Google Scholar
• Cooper D. L., Dougherty G. J. To metastasize or not? Selection of CD44 splice sites. Nat. Med 1995; 1: 635–637
   PubMed Web of Science ®Google Scholar
• de Belder A. N., Wik K. O. Preparation and proper-ties of fluorescein-labelled hyaluronate. Carhohydr. Res 1975; 44: 251–257
   PubMed Web of Science ®Google Scholar
• Eisenberger M. A., Reyno L. M. Suramin. Cancer Treat. Rev 1994; 20: 259–273
   PubMed Web of Science ®Google Scholar
• Fruman D. A., Klee C. B., Bierer B. E., Burakoff S. J. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK506 and cyclosporin A. Proc. Natl. Acad. Sci. USA 1992; 89: 3686–3690
   PubMed Web of Science ®Google Scholar
• Galluzzo E., Albi N., Fiorucci S., Merigiola C., Ruggeri L., Tosti A., Grossi C. E., Velardi A. Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells. Eur. J. Immunol 1995; 25: 2932–2939
   PubMed Web of Science ®Google Scholar
• Gnegy M. E. Calmodulin: Effects of cell stimuli and drugs on cellular activation. Prog. Drug Res 1995; 45: 33–65
   PubMedGoogle Scholar
• Günthert U. CD44 in malignant disorders. Curr. Top. Microbiol. Immunol 1996; 213: 217–285
   PubMed Web of Science ®Google Scholar
• Hunakova L., Sedlak J., Klobusicka M., Sulikova M., Chorvath B. Phorbol ester (TPA)-induced differential modulation of cell surface antigen in human pluripotential leukemia (K-562) cell line: effects of protein kinase inhibitors with broad- and PKC selective inhibitory activity. Neoplasma 1995; 42: 249–253
   PubMed Web of Science ®Google Scholar
• Jackson D. G., Bell J. I., Dickinson R., Timans J., Shields J., Whittle N. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the V3 exon. J. Cell Biol 1995; 128: 673–685
   PubMed Web of Science ®Google Scholar
• Katoh S., Zheng Z., Oritani K., Shimozato T., Kincade P. W. Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J. Exp. Med 1995; 182: 419–429
   PubMed Web of Science ®Google Scholar
• Khan N. A., Meyneil J. P., Deschaux P. Ca2+/calmodulin and protein kinase C regulation of serotonin transport in human K562 lymphocytes. Cell. Immunol 1996; 172: 269–274
   Web of Science ®Google Scholar
• Knudson C. B., Knudson W. Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB J 1993; 7: 1233–1241
   PubMed Web of Science ®Google Scholar
• Knudson W. Tumor-associated hyaluronan. Providing an extracellular matrix that facilitates invasion. Am. J. Pathol 1996; 148: 1721–1726
   PubMed Web of Science ®Google Scholar
• Laurent T. C., Laurent U. B., Fraser J. R. Functions of hyaluronan. Ann. Rheum. Dis 1995; 54: 429–432
   PubMed Web of Science ®Google Scholar
• Lesley J., He Q., Miyake K., Hamann A., Hyman R., Kincade P. W. Requirements for hyaluronic acid binding by CD44: A role for the cytoplasmic domain and activation by antibody. J. Exp. Med 1992; 175: 257–266
   PubMed Web of Science ®Google Scholar
• Lesley J., Hyman R., Kincade P. W. CD44 and its interaction with the extracellular matrix. Adv. Immunol 1993a; 54: 271–335
   PubMed Web of Science ®Google Scholar
• Lesley J., Kincade P. W., Hyman R. Antibody-induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibody. Eur. J. Immunol 1993b; 23: 1902–1909
   PubMed Web of Science ®Google Scholar
• Lesley J., English N., Perschl A., Gregoroff J., Hyman R. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J. Exp. Med 1995; 182: 431–437
   PubMed Web of Science ®Google Scholar
• Lewis R. S., Cahalan M. D. Potassium and calcium channels in lymphocytes. Annu. Rev. Immunol 1995; 13: 623–653
   PubMed Web of Science ®Google Scholar
• Liao H.-X., Levesque M. C., Patton K., Bergamo B., Jones D., Moody M. A., Telen M. J., Haynes B. F. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies. J. Immunol 1993; 151: 6490–6499
   PubMed Web of Science ®Google Scholar
• Liao H.-X., Lee D. M., Levesque M. C., Haynes B. F. N-terminal and central regions of the human CD44 extracellular domain participate in cell surface hyaluronan binding. J. Immunol 1995; 155: 3938–3945
   PubMed Web of Science ®Google Scholar
• Liu D., Zhang D., Mori H., Sy M.-S. Binding of CD44 to hyaluronic acid can be induced by multiple signals and requires the CD44 cytoplasmic domain. Cell. Immunol 1996; 174: 73–83
   PubMed Web of Science ®Google Scholar
• Lokeshwar V. B., Fregien N., Bourguignon L. Y. Ankyrin-binding of CD44 (GP85) is required for the expression of hyaluronic acid-mediated adhesion function. J. Cell Biol 1994; 126: 1099–1109
   PubMed Web of Science ®Google Scholar
• Malgaroli A., Milani D., Meldolesi J., Pozzan T. Fura-2 measurement of cytosolic free Ca2+ in monolayers and suspensions of various types of animal cells. J. Cell Biol 1987; 105: 2145–2155
   PubMed Web of Science ®Google Scholar
• McKnight G. S. Cyclic AMP second messenger systems. Curr. Opin. Cell Biol 1991; 3: 213–217
   PubMed Web of Science ®Google Scholar
• Mtairag E. M., Abdelghaffar H., Douhet C., Labro M. T. Role of extracellular calcium in in vitro uptake and intraphagocytic location of macrolides. Antimicrob. Agents Chemother 1995; 39: 1676–1682
   PubMed Web of Science ®Google Scholar
• Murakami S., Miyake K., June C. H., Kincade P. W., Hodes R. J. IL-5 induces a pgp-1 (CD44) bright B cell subpopulation that is highly enriched in proliferative and Ig secretory activity and binds to hyaluronate. J. Immunol 1990; 145: 3618–3627
   PubMed Web of Science ®Google Scholar
• Murakami S., Shimabukuro Y., Miki Y., Saho T., Hino E., Kasai D., Nozaki T., Kusumoto Y., Okada H. Inducible binding of human lymphocytes to hyaluronate via CD44 does not require cytoskeleton association but does require new protein synthesis. J. Immunol 1994; 152: 467–477
   PubMed Web of Science ®Google Scholar
• Naor D., Sionov Vogt R., Ish-Shalom D. CD44: Structure, function and association with the malignant process. Adv. Cancer Res 1997; 71: 241–319
   PubMed Web of Science ®Google Scholar
• Opie L. H. Calcium channel antagonists in the treatment of coronary artery disease: Fundamental pharmacological properties relevant to clinical use. Prog. Cardiovascular Dis 1996; 38: 273–290
   PubMed Web of Science ®Google Scholar
• Peach R. J., Hollenbaugh D., Stamenkovic I., Aruffo A. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J. Cell Biol 1993; 122: 257–264
   PubMed Web of Science ®Google Scholar
• Peck D., Isacke C. M. CD44 phosphorylation regulates melanoma cell and fibroblast migration on, but not attachment to, a hyaluronan substratum. Curr. Biol 1996; 6: 884–890
   PubMed Web of Science ®Google Scholar
• Perschl A., Lesley J., English N., Trowbridge I., Hyman R. Role of CD44 cytoplasmic domain in hyaluronan binding. Eur. J. Immunol 1995; 25: 495–501
   PubMed Web of Science ®Google Scholar
• Planelles D., Hernandez-Godoy J., Gonzalez-Molina A. Differential effects of the calcium ionophore A23187 and the phorbol ester PMA on lymphocyte proliferation. Agents Actions 1992; 35: 238–244
   PubMedGoogle Scholar
• Puré E., Camp R. L., Peritt D., Panettieri R. A., Jr., Lazaar A. L., Nayak S. Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain. J. Exp. Med 1995; 181: 55–62
   PubMed Web of Science ®Google Scholar
• Rothman M., Moll J., Herrlich P., Wallach B., Nedvetzki S., Sionov Vogt R., Golan I., Ish-Shalom D., Naor D., (Submitted). Cell surface CD44 activation is associated with the synergistic effect of phorbol ester-dependent signaling and receptor deglycosylation
   Google Scholar
• Rosen L. B., Ginty D. D., Greenberg M. E. Calcium regulation of gene expression. Adv. Second Messenger Phosphoprotein Res 1995; 30: 225–253
   PubMedGoogle Scholar
• Ruggiero R. A., Bastuobad O. D., Bonfil R. D., Meiss R. P., Pasqualini C. D. “Concomitant immunity” in murine tumours of non-detectable immunogenicity. Br. J. Cancer 1985; 51: 37–48
   PubMed Web of Science ®Google Scholar
• Screaton G. R., Bell M. V., Jackson D. G., Cornelis F. B., Gerth U., Bell J. I. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl. Acad. Sci. USA 1992; 89: 12160–12164
   PubMed Web of Science ®Google Scholar
• Seger R., Krebs E. G. The MAPK signaling cascade. FASEB J 1995; 9: 726–735
   PubMed Web of Science ®Google Scholar
• Sherman L., Sleeman J., Herrlich P., Ponta H. Hyaluronate receptors: key players in growth, differentiation, migration, and tumor progression. Curr. Opin. Cell. Biol 1994; 6: 726–733
   PubMed Web of Science ®Google Scholar
• Sleeman J. P., Arming S., Moll J. F., Hekele A., Rudy W., Sherman L. S., Kreil G., Ponta H., Herrlich P. Hyaluronate-independent metastatic behaviour of CD44 variant-expressing pancreatic carcinoma cells. Cancer Res 1996; 56: 3134–3141
   PubMed Web of Science ®Google Scholar
• Squires P. E., Amiranoff B., Dunne M. J. Intracellular Ca2+ signals in human-derived pancreatic somatostatinsecreting cells (QGP-1N). Pflugers Arch 1994; 428: 275–282
   PubMed Web of Science ®Google Scholar
• Stamenkovic I., Aruffo A., Amiot M., Seed B. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate bearing cells. EMBO J 1991; 10: 343–348
   PubMed Web of Science ®Google Scholar
• Takahashi K., Stamenkovic I., Cutler M., Dasgupta A., Tanabe K. K. Keratan sulfate modification of CD44 modulates adhesion to hyaluronate. J. Biol. Chem 1996; 271: 9490–9496
   PubMed Web of Science ®Google Scholar
• Tamir A., Granot Y., Isakov N. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase. J. Immunol 1996; 157: 1514–1522
   PubMed Web of Science ®Google Scholar
• Thomas L., Byers H. R., Vink J., Stamenkovic I. CD44H regulates tumor cell migration on hyaluronate-coated substrate. J. Cell Biol 1992; 118: 971–977
   PubMed Web of Science ®Google Scholar
• Tölg C., Hofmann M., Herrlich P., Ponta H. Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res 1993; 21: 1225–1229
   PubMed Web of Science ®Google Scholar
• Tsien R. Y., Poenie M. Fluorescence ratio imaging: a new window into intracellular ionic signaling. TIBS 1986; 11: 450–455
   Web of Science ®Google Scholar
• Tsukita S., Oishi K., Sato N., Sagara J., Kawai A., Tsukita S. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J. Cell Biol 1994; 126: 391–401
   PubMed Web of Science ®Google Scholar
• Uff C. R., Neame S. J., Isacke C. M. Hyaluronan binding by CD44 is regulated by a phosphorylation-independent mechanism. Eur. J. Immunol 1995; 25: 1883–1887
   PubMed Web of Science ®Google Scholar
• van Muijen G. N., Danen E. H., Veerkamp J. H., Ruiter D. J., Lesley J., van den Heuvel L. P. Glycoconjugate profile and CD44 expression on human melanoma cell lines with different metastatic capacity. Int. J. Cancer 1995; 61: 241–248
   PubMed Web of Science ®Google Scholar
• Vogel H. J., Zhang M. Protein engineering and NMR studies of calmodulin. Mol. Cell. Biochem 1995; 149/150: 3–15
   Web of Science ®Google Scholar
• Vogt Sionov R., Naor D. Hyaluronan-independent lodgment of CD44+ lymphoma cells in lymphoid organs. Int. J. Cancer 1997; 71: 462–469
   PubMed Web of Science ®Google Scholar
• Werlen G., Belin D., Conne B., Roche E., Lew D. P., Prentki M. Intracellular Ca2+ and the regulation of early response gene expression in HL-60 myeloid leukemia cells. J. Biol. Chem 1993; 268: 16596–16601
   PubMed Web of Science ®Google Scholar
• Zahalka M. A., Okon E., Gosslar U., Holzmann B., Naor D. Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent. J. Immunol 1995; 154: 5345–5355
   PubMed Web of Science ®Google Scholar
• Zhang L., Underhill C. B., Chen L. Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res 1995; 55: 428–433
   Web of Science ®Google Scholar